199 related articles for article (PubMed ID: 25628462)
1. Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer.
Bowman BM; Sebolt KA; Hoff BA; Boes JL; Daniels DL; Heist KA; Galbán CJ; Patel RM; Zhang J; Beer DG; Ross BD; Rehemtulla A; Galbán S
Sci Signal; 2015 Jan; 8(361):ra9. PubMed ID: 25628462
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD.
Jang MS; Lee SJ; Kim CJ; Lee CW; Kim E
Oncogene; 2011 Jan; 30(4):471-81. PubMed ID: 20890306
[TBL] [Abstract][Full Text] [Related]
3. Cooperative phosphorylation of FADD by Aur-A and Plk1 in response to taxol triggers both apoptotic and necrotic cell death.
Jang MS; Lee SJ; Kang NS; Kim E
Cancer Res; 2011 Dec; 71(23):7207-15. PubMed ID: 21978935
[TBL] [Abstract][Full Text] [Related]
4. Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: functional interactions with casein kinase Ialpha, Galpha(i) proteins, and ERK1/2 signaling.
García-Fuster MJ; Ramos-Miguel A; Miralles A; García-Sevilla JA
Neuropharmacology; 2008 Oct; 55(5):886-99. PubMed ID: 18657552
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities.
Alappat EC; Feig C; Boyerinas B; Volkland J; Samuels M; Murmann AE; Thorburn A; Kidd VJ; Slaughter CA; Osborn SL; Winoto A; Tang WJ; Peter ME
Mol Cell; 2005 Aug; 19(3):321-32. PubMed ID: 16061179
[TBL] [Abstract][Full Text] [Related]
6. Casein kinase 1α-dependent feedback loop controls autophagy in RAS-driven cancers.
Cheong JK; Zhang F; Chua PJ; Bay BH; Thorburn A; Virshup DM
J Clin Invest; 2015 Apr; 125(4):1401-18. PubMed ID: 25798617
[TBL] [Abstract][Full Text] [Related]
7. Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.
Borgal L; Rinschen MM; Dafinger C; Liebrecht VI; Abken H; Benzing T; Schermer B
Cell Cycle; 2016; 15(8):1034-45. PubMed ID: 26919559
[TBL] [Abstract][Full Text] [Related]
8. Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK.
Wang J; Hu K; Guo J; Cheng F; Lv J; Jiang W; Lu W; Liu J; Pang X; Liu M
Nat Commun; 2016 May; 7():11363. PubMed ID: 27193833
[TBL] [Abstract][Full Text] [Related]
9. The kinase PLK1 promotes the development of
Kong Y; Allison DB; Zhang Q; He D; Li Y; Mao F; Li C; Li Z; Zhang Y; Wang J; Wang C; Brainson CF; Liu X
Sci Signal; 2022 Oct; 15(754):eabj4009. PubMed ID: 36194647
[TBL] [Abstract][Full Text] [Related]
10. Bora and Aurora-A continue to activate Plk1 in mitosis.
Bruinsma W; Macurek L; Freire R; Lindqvist A; Medema RH
J Cell Sci; 2014 Feb; 127(Pt 4):801-11. PubMed ID: 24338364
[TBL] [Abstract][Full Text] [Related]
11. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.
Chen G; Bhojani MS; Heaford AC; Chang DC; Laxman B; Thomas DG; Griffin LB; Yu J; Coppola JM; Giordano TJ; Lin L; Adams D; Orringer MB; Ross BD; Beer DG; Rehemtulla A
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12507-12. PubMed ID: 16109772
[TBL] [Abstract][Full Text] [Related]
13. Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma.
Marín-Rubio JL; de Arriba MC; Cobos-Fernández MA; González-Sánchez L; Ors I; Sastre I; Fernández-Piqueras J; Villa-Morales M
Oncotarget; 2016 Sep; 7(38):61485-61499. PubMed ID: 27556297
[TBL] [Abstract][Full Text] [Related]
14. Purification and proteomic identification of putative upstream regulators of polo-like kinase-1 from mitotic cell extracts.
Ji JH; Hwang HI; Lee HJ; Hyun SY; Kang HJ; Jang YJ
FEBS Lett; 2010 Oct; 584(20):4299-305. PubMed ID: 20869364
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis.
Zhang F; Virshup DM; Cheong JK
Oncogene; 2018 Jan; 37(3):363-376. PubMed ID: 28945225
[TBL] [Abstract][Full Text] [Related]
16. MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling.
Huang Q; Chen L; Schonbrunn E; Chen J
EMBO J; 2020 Jul; 39(14):e104410. PubMed ID: 32511789
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
Lin YC; Sun SH; Wang FF
Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
[TBL] [Abstract][Full Text] [Related]
18. FADD-calmodulin interaction: a novel player in cell cycle regulation.
Papoff G; Trivieri N; Crielesi R; Ruberti F; Marsilio S; Ruberti G
Biochim Biophys Acta; 2010 Aug; 1803(8):898-911. PubMed ID: 20420860
[TBL] [Abstract][Full Text] [Related]
19. A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS.
Pang X; Liu M
Chin J Cancer; 2016 Oct; 35(1):92. PubMed ID: 27793187
[TBL] [Abstract][Full Text] [Related]
20. Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis.
Sinnberg T; Menzel M; Kaesler S; Biedermann T; Sauer B; Nahnsen S; Schwarz M; Garbe C; Schittek B
Cancer Res; 2010 Sep; 70(17):6999-7009. PubMed ID: 20699366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]